Login

James P. Scriven, CEO of IDB Invest, focuses on Latin American finance and development in collaboration with the International Finance Corporation. 00:10:00

Share On Facebook Share On Twitter

James P. Scriven, CEO of IDB Invest

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Parfit: A Philosopher's Quest for Moral Objectivity|David Edmonds,Professor,BBC World Service
00:10:00
Backs very early-stage founders on both coasts, often before they have a product|Michael Hirshland,Co-Founder,Resolute Ventures
00:10:00
Bloomberg Talks with Ranesh Ramanathan: Banks Forge New Paths into Direct Lending Arena | Ranesh Ramanathan - Partner, akin gump strauss hauer & feld llp
00:10:00
Scholarship means a door of opportunity|Onsi Sawiris,Co-Founder and Managing Partner,HOF Capital
00:10:00
Exploring Gold in West Africa: Insights from Fluido's First One-to-One Conference in London
00:10:00
An interview with Alice Melpignano, CEO of NeosVoc, on LEFONTI TV, discussing innovations and insights from Neosperience S.p.A.
00:10:00
In-Depth Conversation with Bob Prince, Co-CIO of Bridgewater Associates: Exploring the New Paradigm, Strategic Asset Allocation, and Combining Beta and Alpha
00:10:00
Kingsrose Mining Ltd. diversifies its asset portfolio through the sale of the Way Linggo gold project and progresses exploration efforts, including a significant EM anomaly discovery at the Porsanger project and initiating permitting for drilling at the P
00:10:00
Insights into Equity & Hybrid Investments: Apollo Investor Day 2021 | Scott Kleinman - Co-President, Apollo Asset Management
00:00:00
Andrew J. Bentall, M.B., Ch.B., M.D. Nephrologist, Mayo Clinic / Mayo Clinic Explains Kidney Disease
00:00:00
e-Therapeutics PLC using its drug discovery platform - Jonny Wray, CTO, E-Therapeutics PLC
00:10:00
Embracing the Future: Wisdom Tree's Journey into Digital Assets and Tokenization |   Jonathan Steinberg, CEO ,WisdomTree Investments.

© 2017 - Neuhu+